Catalent Inc (0C8.SG)
| Previous close | 51.45 |
| Open | 53.00 |
| Bid | 0.00 x 300000 |
| Ask | 0.00 x 300000 |
| Day's range | 53.00 - 61.87 |
| 52-week range | 39.41 - 112.06 |
| Volume | |
| Avg. volume | 3 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
Danaher Takes Interest in Life Sciences Firm Catalent
(Bloomberg) -- Life sciences company Danaher Corp. has expressed takeover interest in contract manufacturer Catalent Inc., according to people familiar with the matter. Most Read from BloombergStrongest Quake in Decades Kills Hundreds in Turkey, SyriaChina Moves From Contrite to Confrontational Over US BalloonUS Moves to Recover Chinese Balloon While Weighing RetaliationUS Downs Chinese Balloon, Prompting Protests from BeijingTrump Offers $1 Million Bond to Appeal Clinton Suit SanctionsThe overt
- Zacks
Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?
Catalent's (CTLT) Q2 results are likely to have been driven by robust segmental performances.
- Zacks
Catalent (CTLT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Catalent (CTLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
